Arcutis Biotherapeutics Inc (ARQT) USD0.0001
2.03%- This stock can be held in a
Stocks and Shares ISASell:$8.46
Buy:$8.47
Change:
$0.03 (0.29%)
$0.03 (0.29%)Market closed | Prices delayed by at least 15 minutes
Sell:$8.46
Buy:$8.47
Change:$0.03 (0.29%)
$0.03 (0.29%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 March 2024 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 21,052 | $9.50 | $199,994.00 | 8,785,284 |
| 4 March 2024 | Todd Franklin WatanabePresident/CEO | Sell Option/Award related | 14,903 | $11.12 | $165,739.24 | 874,533 |
| 4 March 2024 | Patrick BurnettChief Level Officer | Sell Option/Award related | 4,782 | $11.12 | $53,181.58 | 269,300 |
| 4 March 2024 | Masaru (Mas) MatsudaCompany Secretary | Sell Option/Award related | 3,760 | $11.12 | $41,815.71 | 190,424 |
| 4 March 2024 | Matthew Richard MooreSenior Vice President | Sell Option/Award related | 3,468 | $11.12 | $38,568.32 | 146,020 |
| 28 February 2024 | Todd Franklin WatanabePresident/CEO | Sell Tax related | 2,465 | $10.60 | $26,129.00 | 889,436 |
| 2 January 2024 | Patrick BurnettChief Level Officer | Sell Tax related | 1,325 | $3.54 | $4,691.56 | 57,032 |
| 21 November 2023 | Masaru (Mas) MatsudaCompany Secretary | Sell Tax related | 1,850 | $1.98 | $3,661.15 | 46,634 |
| 24 October 2023 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 80,000 | $2.50 | $200,000.00 | 8,764,232 |
| 21 August 2023 | Patrick BurnettChief Level Officer | Sell Tax related | 300 | $7.05 | $2,115.00 | 59,662 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 October 2023 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 80,000 | $2.50 | $200,000.00 | 8,764,232 |
| 4 March 2024 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 21,052 | $9.50 | $199,994.00 | 8,785,284 |
| 4 March 2024 | Todd Franklin WatanabePresident/CEO | Sell Option/Award related | 14,903 | $11.12 | $165,739.24 | 874,533 |
| 4 March 2024 | Patrick BurnettChief Level Officer | Sell Option/Award related | 4,782 | $11.12 | $53,181.58 | 269,300 |
| 4 March 2024 | Masaru (Mas) MatsudaCompany Secretary | Sell Option/Award related | 3,760 | $11.12 | $41,815.71 | 190,424 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.